French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy

Sponsor
Assistance Publique - Hôpitaux de Paris
Study ID
NCT07428031
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study aims to create a registry of patients with hypertrophic cardiomyopathy, a condition characterized by excessive thickening of the heart muscle. This disease can sometimes lead to serious complications. Currently, the prognosis of these patients is mainly determined by clinical and echocardiographic parameters. Detection of myocardial fibrosis using cardiac MRI enables better risk stratification for these patients.

Key Dates

Start date
Mar 1, 2026
Status verified
Feb 2026
Primary completion
Mar 1, 2031
Completion
Mar 1, 2036

Study Design

Enrollment
5,000 participants (estimated)

Primary Outcome Measure

To build a score using the "LGE granularity" concept for all-cause mortality prediction in HCM patients. [ Time Frame: From Baseline to 5 years ]

Central Contacts

Related Studies